Kate Ridout

464 total citations
4 papers, 13 citations indexed

About

Kate Ridout is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Kate Ridout has authored 4 papers receiving a total of 13 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Kate Ridout's work include Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Kate Ridout is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Kate Ridout collaborates with scholars based in United Kingdom, Sweden and Switzerland. Kate Ridout's co-authors include Pauline Robbe, Mark J. Caulfield, Samantha J.L. Knight, Pavlos Antoniou, Adam Burns, David Bentley, Hélène Dreau, Ruth Clifford, Anna Schuh and Jenny Klintman and has published in prestigious journals such as Blood, British Journal of Haematology and Clinical Lymphoma Myeloma & Leukemia.

In The Last Decade

Kate Ridout

3 papers receiving 13 citations

Peers

Kate Ridout
Heather Zimmermann United States
Janet Schmid United States
Sarah J. Farndon United Kingdom
Pablo Kalfayan Argentina
Yuping Li United States
Megan Manion United States
Kate Ridout
Citations per year, relative to Kate Ridout Kate Ridout (= 1×) peers Joerg Reichrath

Countries citing papers authored by Kate Ridout

Since Specialization
Citations

This map shows the geographic impact of Kate Ridout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Ridout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Ridout more than expected).

Fields of papers citing papers by Kate Ridout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Ridout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Ridout. The network helps show where Kate Ridout may publish in the future.

Co-authorship network of co-authors of Kate Ridout

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Ridout. A scholar is included among the top collaborators of Kate Ridout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Ridout. Kate Ridout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Klintman, Jenny, Basile Stamatopoulos, Kate Ridout, et al.. (2019). PF376 DIFFERENTIAL GENOMIC AND TRANSCRIPTOMIC EVENTS ASSOCIATED WITH HIGH-GRADE TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA. HemaSphere. 3(S1). 139–140.
2.
Ridout, Kate, Pauline Robbe, Dimitris Vavoulis, et al.. (2018). The Genomic Landscape of Chronic Lymphocytic Leukaemia: Clinical Implications. Clinical Lymphoma Myeloma & Leukemia. 18. S112–S115. 1 indexed citations
3.
Klintman, Jenny, Samantha J.L. Knight, Pauline Robbe, et al.. (2018). Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL. British Journal of Haematology. 182(3). 412–417. 11 indexed citations
4.
Robbe, Pauline, Kate Ridout, Jennifer Becq, et al.. (2016). Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot. Blood. 128(22). 2022–2022. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026